VU 0364439 100mg 100mg | Purity Not Available
Adooq Bioscience
VU 0364439 is a positive allosteric modulator (PAM) of mGlu4 receptors (EC50 = 19.8 nM in vitro for human mGlu4).
More Information Supplier PageVU 0364439 is a positive allosteric modulator (PAM) of mGlu4 receptors (EC50 = 19.8 nM in vitro for human mGlu4).
More Information Supplier PageVU 0364439 is a positive allosteric modulator (PAM) of mGlu4 receptors (EC50 = 19.8 nM in vitro for human mGlu4).
More Information Supplier PageAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageAmrubicin is a synthetic anthracycline antibiotic. It inhibits DNA topoisomerase II. Antineoplastic.
More Information Supplier PageSalvianolic Acid B is isolated and purified from the crude extract of Salvia miltiorrhiza.
More Information Supplier PageSalvianolic Acid B is isolated and purified from the crude extract of Salvia miltiorrhiza.
More Information Supplier PageSalvianolic Acid B is isolated and purified from the crude extract of Salvia miltiorrhiza.
More Information Supplier PageONX 0914 is an immunoproteasome inhibitor with potential treatment applications in autoimmune disorders, such as rheumatoid arthritis, inflammatory bowel disease and lupus. ONX 0914 was designed to be a potent inhibitor of the immunoproteasome with minimal cross-reactivity for the constitutive proteasome.
More Information Supplier Page